This study investigates pancreatic cystic lesions. The purpose of this study is to use artificial intelligence (AI) to help doctors differentiate between mucinous and non-mucinous cystic lesions.
The study evaluates how well the AI model works in assessing risks and managing care for patients with these lesions.
- Who can participate: Adults 18 and older with pancreatic cystic lesions indicated by EUS results can participate. Key factors include the presence of mucinous or non-mucinous lesions.
- Study details: Participants will provide EUS imaging data, along with radiological and laboratory tests. The study will use this information to develop an AI model for diagnosis and management.